1. 2021
  2. Planned Cesarean or planned vaginal delivery for twins: secondary analysis of randomized controlled trial

    the Twin Birth Study Collaborative Group, 1 Apr 2021, In: Ultrasound in obstetrics & gynecology. 57, 4, p. 582-591 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2020
  4. Validation of a treatment-selection rule for patients with advanced stage ovarian cancer

    van de Vrie, R., van Werkhoven, E., Rutten, M. J., Asseler, J. D., van Meurs, H. S., Werter, D. E., Buist, M. R., Zwinderman, A. H., Lok, C. A. R., Bossuyt, P. M. M., Kenter, G. G. & Tajik, P., 1 Dec 2020, In: European journal of gynaecological oncology. 41, 6, p. 1023-1030 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Gene-environment Interaction on the Risk of Type 2 Diabetes Among Ethnic Minority Populations Living in Europe and North America: A Systematic Review

    Zafarmand, M. H., Tajik, P., Spijker, R. & Agyemang, C., 2020, In: Current diabetes reviews. 16, 5, p. 457-470 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2019
  7. Always randomize as late as possible

    van Werkhoven, E., Tajik, P. & Bossuyt, P. M., Nov 2019, In: Gastric cancer. 22, 6, p. 1308-1309

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. 2018
  9. Development and evaluating multimarker models for guiding treatment decisions

    Tajik, P., Zafarmand, M. H., Zwinderman, A. H., Mol, B. W. & Bossuyt, P. M., 2018, In: BMC medical informatics and decision making. 18, 1, 52.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials

    Kang, C., Janes, H., Tajik, P., Groen, H., Mol, B., Koopmans, C., Broekhuijsen, K., Zwertbroek, E., van Pampus, M. & Franssen, M., 2018, In: Statistics in medicine. 37, 9, p. 1439-1453

    Research output: Contribution to journalArticleAcademicpeer-review

  11. The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy

    Tajik, P., van de Vrie, R., Zafarmand, M. H., Coens, C., Buist, M. R., Vergote, I., Bossuyt, P. M. M. & Kenter, G. G., 2018, In: International journal of gynecological cancer. 28, 3, p. 453-458

    Research output: Contribution to journalArticleAcademicpeer-review

  12. 2017
  13. Blood pressure patterns in women with gestational hypertension or mild preeclampsia at term

    van der Tuuk, K., Tajik, P., Koopmans, C. M., van den Berg, P. P., Mol, B. W. J., van Pampus, M. G. & Groen, H., 2017, In: European journal of obstetrics, gynecology, and reproductive biology. 210, p. 360-365

    Research output: Contribution to journalArticleAcademicpeer-review

  14. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers

    Tjon-Kon-Fat, R. I., Tajik, P., Zafarmand, M. H., Bensdorp, A. J., Bossuyt, P. M. M., Oosterhuis, G. J. E., van Golde, R., Repping, S., Lambers, M. D. A., Slappendel, E., Perquin, D., Pelinck, M. J., Gianotten, J., Maas, J. W. M., Eijkemans, M. J. C., van der Veen, F., Mol, B. W. & van Wely, M., 2017, In: Human reproduction (Oxford, England). 32, 5, p. 1028-1032

    Research output: Contribution to journalArticleAcademicpeer-review

  15. 2016
  16. A multivariable model to guide the decision for pessary placement to prevent preterm birth in women with a multiple pregnancy: a secondary analysis of the ProTWIN trial

    Tajik, P., Monfrance, M., van 't Hooft, J., Liem, S. M. S., Schuit, E., Bloemenkamp, K. W. M., Duvekot, J. J., Nij Bijvank, B., Franssen, M. T. M., Oudijk, M. A., Scheepers, H. C. J., Sikkema, J. M., Woiski, M., Mol, B. W. J., Bekedam, D. J., Bossuyt, P. M. & Zafarmand, M. H., 2016, In: Ultrasound in obstetrics & gynecology. 48, 1, p. 48-55

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 Next

ID: 88559